Does SPIRONOLACTONE Cause Product formulation issue? 11 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Product formulation issue have been filed in association with SPIRONOLACTONE (spironolactone). This represents 0.1% of all adverse event reports for SPIRONOLACTONE.
11
Reports of Product formulation issue with SPIRONOLACTONE
0.1%
of all SPIRONOLACTONE reports
0
Deaths
3
Hospitalizations
How Dangerous Is Product formulation issue From SPIRONOLACTONE?
Of the 11 reports, 3 (27.3%) required hospitalization, and 1 (9.1%) were considered life-threatening.
Is Product formulation issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SPIRONOLACTONE. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does SPIRONOLACTONE Cause?
Acute kidney injury (3,273)
Hyperkalaemia (2,518)
Hypotension (1,583)
Dyspnoea (1,468)
Drug ineffective (1,379)
Hyponatraemia (1,166)
Dizziness (991)
Fatigue (990)
Fall (947)
Off label use (899)
What Other Drugs Cause Product formulation issue?
MINOXIDIL (1,369)
LEVOTHYROXINE (740)
AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (174)
OMEPRAZOLE (99)
METHYLPHENIDATE (78)
OXYCODONE (73)
ACETAMINOPHEN\HYDROCODONE (62)
ACETAMINOPHEN\OXYCODONE (61)
ACETAMINOPHEN (59)
BUPROPION (59)
Which SPIRONOLACTONE Alternatives Have Lower Product formulation issue Risk?
SPIRONOLACTONE vs SPRYCEL
SPIRONOLACTONE vs STALEVO
SPIRONOLACTONE vs STANNOUS FLUORIDE
SPIRONOLACTONE vs STANOZOLOL
SPIRONOLACTONE vs STAVUDINE